GlassScriptPhysician profile
Ashesh H Sanghvi
NPI 1336185685
$1,736.64
in general payments reported to CMS, 2019-2025
16 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $107 · 2021: $45.62 · 2022: $731 · 2023: $240 · 2024: $56.39 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357 · Education: $93.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.55 |
| Education | $93.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $245.65 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $245.21 | 2022-2023 | Zeposia |
| Medtronic, INC. | $234.46 | 2021-2022 | |
| Janssen Biotech, INC. | $186.04 | 2019-2025 | Tremfya |
| Gilead Sciences, INC. | $157.64 | 2019-2020 | |
| Lucid Diagnostics INC. | $142.96 | 2022 | |
| Celgene Corporation | $131.88 | 2022-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $102.26 | 2019-2025 | Entyvio |
| Pfizer INC. | $77.38 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.24 | 2019-2023 | Trulance |
| Shionogi INC | $31.47 | 2019 | |
| Allergan, INC. | $27.77 | 2019 | |
| Boston Scientific Corporation | $24.02 | 2025 | General - Pain Management |
| Genzyme Corporation | $21.55 | 2022 | |
| Ironwood Pharmaceuticals, INC | $17.87 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $15.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashesh Sanghvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.